Back to FA Focus Advisor Solutions, LLC

NKTRNKTR

2 quarters

Position history for FAFocus Advisor Solutions, LLC's holdings in Nektar Therapeutics

As of its Q1 2025 13F, Focus Advisor Solutions held 19,433 shares of NKTR (Nektar Therapeutics), worth $13,218.

Final Value

$0

Final Shares

0

Total Value Change

-$13,218

Total Shares Change

-19,433

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$25.84
0
2025-Q1
New
19,433
—
$13,2180.0%$10.20
25

Optional analytics helps us improve. How it’s used